Cover Image

Guidance for industry : IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer.

Bibliographic Details
Corporate Authors: Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.)
Format: Government Document eBook
Language:English
Published: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2004]
Subjects:
Medicine, Experimental > Government policy > United States.
Clinical trials > Government policy > United States.
Cancer > Treatment > United States.
Online Access:https://purl.fdlp.gov/GPO/LPS116353
Description
Item Description:"Center for Biologics Evaluation and Research (CBER)."
"Clinical medical."
"Revision 1."
"January 2004."
Electronic resource.
Physical Description:1 online resource (8 pages)